CLINICAL TRIALS PROFILE FOR NEXPLANON
✉ Email this page to a colleague
All Clinical Trials for NEXPLANON
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01397097 ↗ | LCS12 vs. ENG Subdermal Implant (Nexplanon) Discontinuation Rate Study | Completed | Bayer | Phase 3 | 2011-09-01 | The primary objective is to demonstrate that discontinuation rates in women (ages 18-35 years inclusive) using LCS12 are not higher than those seen in women using ENG subdermal implant over a period of 12 months. Secondary objectives are to observe the bleeding patterns, adverse event profiles and the occurrence of unintended pregnancies. Additionally, data on user satisfaction, IUS expulsions and implant site complications will be collected. |
| NCT01438736 ↗ | Is Cerazette Use Before Nexplanon Insertion Predictive for Bleeding Pattern? | Unknown status | Merck Sharp & Dohme Corp. | Phase 4 | 2011-09-01 | The purpose of the study is to examine how well three months preceding use of Cerazette progestin only pill predicts the bleeding pattern during following Nexplanon implant use. |
| NCT01438736 ↗ | Is Cerazette Use Before Nexplanon Insertion Predictive for Bleeding Pattern? | Unknown status | VL-Medi Oy | Phase 4 | 2011-09-01 | The purpose of the study is to examine how well three months preceding use of Cerazette progestin only pill predicts the bleeding pattern during following Nexplanon implant use. |
| NCT01767285 ↗ | Immediate vs. Delayed Postpartum Etonogestrel Implant | Completed | Duke University | Phase 4 | 2013-01-01 | The investigators are examining if there is a difference in continuation rates of the etonogestrel contraceptive implant between women who have the device placed immediately after delivery, before leaving the hospital, and women who have the device placed at the routine 6-week postpartum visit. There will be 60 subjects total, randomized in a 1:1 ratio, for 30 in each group. All participants will follow-up at the same postpartum clinic 6 weeks after delivery. They will then be contacted at 3, 6, and 12 months postpartum and asked to complete a brief survey. The investigators hypothesize that continuation rates of Implanon will be higher in the immediate postpartum placement arm than in the delayed placement arm. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for NEXPLANON
Condition Name
Clinical Trial Locations for NEXPLANON
Trials by Country
Clinical Trial Progress for NEXPLANON
Clinical Trial Phase
Clinical Trial Sponsors for NEXPLANON
Sponsor Name
